title: [Should we include seropositive patients in autotransfusion programs?].
authors.affiliation: Unidad de Hemoterapia del Hospital Comarcal Mòra d'Ebre, Tarragona.
authors.forename: M J
authors.initials: MJ
authors.lastname: Herranz Martí
authors.forename: A
authors.initials: A
authors.lastname: Peró Silva
mesh_terms: D001771:Blood Banks / Q000592:standards*; D016063:Blood Loss, Surgical; D001804:Blood Transfusion, Autologous / Q000592:standards; D000075202:Contraindications; D004921:Erythropoietin / Q000627:therapeutic use; D015658:HIV Infections / Q000097:blood / Q000628:therapy*; D006679:HIV Seropositivity; D006801:Humans; D019300:Medical Errors / Q000517:prevention & control; D011994:Recombinant Proteins / Q000627:therapeutic use; D018570:Risk Assessment; D012449:Safety
chemical_list: D011994:Recombinant Proteins; D004921:Erythropoietin